– UK, London – The Bankers Investment Trust PLC (LON: BNKR) today announced the appointment of Ankush Nandra to its Board as a Non-executive Director effective from 1 September 2023.
“We are delighted that, following a thorough search process assisted by an independent consultancy firm Ankush has agreed to join the Board. He is a qualified accountant with extensive financial management and accounting experience gained through several roles in industry and will bring a broad range of experience and perspective. We are confident that Ankush will be an excellent addition to the Board”, said Board Chair, Simon Miller.
Ankush Nandra will also join the Audit Committee as Chair, and the Management Engagement, Nominations, and Insider Committees as a member.
About Ankush Nandra
Ankush Nandra has over 20 years’ experience mainly in the pharmaceutical industry. He is currently VP of Finance and CFO of International Region and Enabling Units at AstraZeneca. Before joining AstraZeneca Ankush spent several years at GlaxoSmithKline and has also worked with HSBC Investment Bank following qualification as a Chartered Accountant with KPMG.
Ankush Nandra is a Non-executive Director of AstraZeneca Pharma India Limited which is an Indian listed subsidiary of AstraZeneca. He is also a Non-executive Director and Governor of Oxford Brookes University.
SOURCE: https://www.bankersinvestmenttrust.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
